Clinical Trials Browser

Phase 2 × Mouth Neoplasms × Standard of Care × Clear all

NCT06532279 2026-02-02

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Carcinoma, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms, Stomatitis

NCT07254962 2025-11-28

CAPTURE

Phase 2 Not yet recruiting

75 enrolled

Head & Neck

Head and Neck Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms

NCT04870762 2025-10-08

Customized 3D Printed Oral Stents During Head and Neck Radiotherapy

Phase 2 Recruiting

119 enrolled

Head & Neck

Maxillary Sinus Neoplasms, Mouth Neoplasms, Parotid Neoplasms, Tongue Neoplasms, Tonsillar Neoplasms